Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kathleen Eisenach"'
Autor:
Anne-Marie Demers, Soyeon Kim, Sara McCallum, Kathleen Eisenach, Michael Hughes, Linda Naini, Alberto Mendoza-Ticona, Neeta Pradhan, Kim Narunsky, Selvamuthu Poongulali, Sharlaa Badal-Faesen, Caryn Upton, Elizabeth Smith, N. Sarita Shah, Gavin Churchyard, Amita Gupta, Anneke Hesseling, Susan Swindells, for the ACTG A5300/IMPAACT I2003 PHOENIx Feasibility study team
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Drug susceptibility testing (DST) patterns of Mycobacterium tuberculosis (MTB) from patients with rifampicin-resistant tuberculosis (RR-TB) or multidrug-resistant TB (MDR-TB; or resistant to rifampicin and isoniazid (INH)), are im
Externí odkaz:
https://doaj.org/article/fc245c98756940ee99bd85cedb666055
Autor:
Tara C. Bouton, Patrick P. J. Phillips, Carole D. Mitnick, Charles A. Peloquin, Kathleen Eisenach, Ramonde F. Patientia, Leonid Lecca, Eduardo Gotuzzo, Neel R. Gandhi, Donna Butler, Andreas H. Diacon, Bruno Martel, Juan Santillan, Kathleen Robergeau Hunt, Dante Vargas, Florian von Groote-Bidlingmaier, Carlos Seas, Nancy Dianis, Antonio Moreno-Martinez, C. Robert Horsburgh
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-8 (2017)
Abstract Background Current guidelines for treatment of multidrug-resistant tuberculosis (MDR-TB) are largely based on expert opinion and observational data. Fluoroquinolones remain an essential part of MDR-TB treatment, but the optimal dose of fluor
Externí odkaz:
https://doaj.org/article/e3565cd03ee94d49b1852c372471d7a4
Publikováno v:
PLoS Medicine, Vol 16, Iss 7, p e1002842 (2019)
Externí odkaz:
https://doaj.org/article/edead2a0c4484caaa6ccbd1ab1f6721d
Autor:
Antonino Catanzaro, Timothy C Rodwell, Donald G Catanzaro, Richard S Garfein, Roberta L Jackson, Marva Seifert, Sophia B Georghiou, Andre Trollip, Erik Groessl, Naomi Hillery, Valeriu Crudu, Thomas C Victor, Camilla Rodrigues, Grace Shou-Yean Lin, Faramarz Valafar, Edward Desmond, Kathleen Eisenach
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136861 (2015)
The aim of this study was to compare the performance of several recently developed assays for the detection of multi- and extensively drug-resistant tuberculosis (M/XDR-TB) in a large, multinational field trial.Samples from 1,128 M/XDR-TB suspects we
Externí odkaz:
https://doaj.org/article/df2d5307077e439796b84e5699c652b5
Autor:
Robert S Wallis, Rodney Dawson, Sven O Friedrich, Amour Venter, Darcy Paige, Tong Zhu, Annette Silvia, Jason Gobey, Craig Ellery, Yao Zhang, Kathleen Eisenach, Paul Miller, Andreas H Diacon
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e94462 (2014)
Sutezolid (PNU-100480) is a linezolid analog with superior bactericidal activity against Mycobacterium tuberculosis in the hollow fiber, whole blood and mouse models. Like linezolid, it is unaffected by mutations conferring resistance to standard TB
Externí odkaz:
https://doaj.org/article/1d2f4c6c83044d40877fbbf4225b55e9
Autor:
William R Mac Kenzie, Charles M Heilig, Lorna Bozeman, John L Johnson, Grace Muzanye, Denise Dunbar, Kenneth C Jost, Lois Diem, Beverly Metchock, Kathleen Eisenach, Susan Dorman, Stefan Goldberg
Publikováno v:
PLoS ONE, Vol 6, Iss 4, p e18358 (2011)
Tuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2 clinical trial examining smear positive pulmonary Mycobacterium tuberculosis. Over the course of intensive phase therapy, patients from African sites
Externí odkaz:
https://doaj.org/article/63b3f7d045b246268d447631d366c1ee
Autor:
Christopher C Whalen, Sarah Zalwango, Allan Chiunda, LaShaunda Malone, Kathleen Eisenach, Moses Joloba, W Henry Boom, Roy Mugerwa
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e16137 (2011)
Tuberculosis is an ancient disease that continues to threaten individual and public health today, especially in sub-Saharan Africa. Current surveillance systems describe general risk of tuberculosis in a population but do not characterize the risk to
Externí odkaz:
https://doaj.org/article/b6d912a2c4bf405e98510623b8403684
Publikováno v:
Pediatrics. 97:155-160
Objective. We evaluated the usefulness of the polymerase chain reaction (PCR) using the insertion sequence IS6110 as the target for DNA to detect Mycobacterium tuberculosis in clinical specimens from children. Study Design. This was a prospective, co
Publikováno v:
Diagnostic Microbiology and Infectious Disease. 15:225-231
A new nonradiometric BACTEC medium has been developed for culturing pediatric blood samples. The BACTEC PEDS Plus medium (BACTEC PED) consists of 20 ml of an enriched broth with resins. In contrast to the other aerobic BACTEC media, there is a lower
Autor:
Kathleen Eisenach
Publikováno v:
Human Pathology. 26:931-932